edwinatasman73/9805973
1
0
Code Issues Actions Packages Projects Wiki

Add hCG for Men: Uses, Safety, and Side Effects

Edwina Tasman 2026-04-03 00:06:56 +00:00
commit 43b3a35ba3
1 changed files with 9 additions and 0 deletions
Show Stats Download Patch File Download Diff File Expand all files Collapse all files

9
hCG-for-Men%3A-Uses%2C-Safety%2C-and-Side-Effects.md Normal file

@ -0,0 +1,9 @@
<br>
<br>It’s crucial to discuss the risks and benefits of HCG with a healthcare provider before starting this treatment. Of course, although difficult, randomized studies using control groups for comparison are necessary to confirm the clinical and physiological significance of this treatment regimen. If repeated, studies can consider use of a standardized patient questionnaire, such as a qADAM questionnaire. It should be noted that 6 men who started hCG therapy failed to follow up after the initial 3-month follow-up visit, and therefore fell out of the study. We also found a strong relationship between both hCG dosage and duration of therapy with percent testosterone changes.
The literature indicates that men with lower baseline testosterone levels are more likely to experience PSA level increases. In men with elevated Hct and low/normal on-treatment testosterone levels, measuring a SHBG level and a free [buy testosterone steroids](https://git.cjcrace.io/maricela19r435) level using a reliable assay is suggested. In men with elevated Hct and high on-treatment testosterone levels, dose adjustment should be attempted as first-line management. Several validated questionnaires are used as screening tools to identify men at high risk for testosterone deficiency, but there is an absence of concordance among the questionnaires as to what symptoms are related to low testosterone or to what extent these symptoms improve with treatment. The use of validated questionnaires is not currently recommended to either define which patients are candidates for testosterone therapy or monitor symptom response in patients on testosterone therapy.
The development of the evidence report was particularly challenging in the testosterone space due to the heterogeneity in the literature resulting in difficulties comparing data across studies. There are several areas in the [testosterone shop](https://ztube.com.br/@carenreynolds?page=about) deficiency space, more specifically, epidemiology, diagnosis, treatment and adverse events, which warrant more detailed investigation. In this clinical scenario, an argument can be made to continue testosterone therapy. An exception can be made if patients do not have symptoms but have documented BMD loss. Patients who are on long-acting IM testosterone (testosterone undecanoate) should have blood work tested once steady state levels have been achieved. Although steady-state levels are generally reached within days following commencement, a longer interval takes into account the potential decreases in endogenous testosterone production when on exogenous [order testosterone online](https://flirta.online/@glenwill175907). Patients who have been prescribed testosterone should have regular laboratory testing conducted to confirm that therapeutic levels of testosterone are maintained, especially given the suppression of LH by exogenous testosterone and the subsequent decrease in endogenous [testosterone shop](http://gogs.zlhuiyun.com/deniselain3628) production by the testes.
Men who have a history of chronic corticosteroid use have been shown to be at risk for low testosterone levels. A survey of 120 patients who were treated for infertility at the University of Illinois-Chicago found that the incidence of testosterone deficiency was 45% in men with non-obstructive azoospermia, 42.9% in men with oligospermia, and 16.7% in men with obstructive azoospermia.159 BMD increased in patients treated with [testosterone order](https://pattern-wiki.win/wiki/User:StephenFong5) therapy leading the authors to conclude that younger testosterone deficient men may benefit from having routine DEXA scans performed, particularly those with concomitant low E2 and low BMI.89
Evidence suggests that 2,000 international units (IU) of hCG per week for 6 months may constitute a safe dosage. These cells are the primary means via which the male body produces [testosterone for sale](http://repo.atamiso.com/margenepoling/margene1999/wiki/Association+of+sex+hormones+and+C-reactive+protein+levels+in+men). However, hCG likely promotes [buy testosterone injections](https://www.musicsound.ca/judye523171291) production by stimulating Leydig cells in the testicles.
It is the opinion of this Panel that total testosterone should be tested after the commencement of therapy at a time point that allows a patient to be sufficiently established on a dosing regimen before determining if therapeutic levels have been achieved and if dosing alterations are required. Studies that randomized overweight or obese men to diet and exercise programs had significantly greater increases in total testosterone levels than men who underwent calorie reduction or exercise programs alone.378, 379 It is also postulated that men who engage in quantitatively more exercise have the greatest increases in serum testosterone from baseline.378 Until there is definitive evidence proving an association between testosterone therapy and subsequent MACE, the Panel recommends that clinicians counsel patients that the current scientific literature does not definitively demonstrate that testosterone therapy increases risk. A study by Pastuszak et al. (2015)355 found a significant increase in biochemical recurrence in high-risk patients who received [buy testosterone enanthate](https://heywhatsgoodnow.com/@lilianadunham) therapy after RT or RT/ADT. Currently published studies have not demonstrated an increased risk of biochemical cancer recurrence in post-RP patients who are on testosterone therapy, nor does it define the optimal timing for commencement of testosterone therapy. At the end of the study, serum [testosterone buy online](http://154.39.79.147:3000/latonyaelizond) levels rose in those men receiving testosterone therapy; however, no rise in [testosterone shop](https://git.davisdre.com/elmer51b922872) levels were seen within the prostate tissue itself.
In our series, a single patient had Sertoli-cell only on testis biopsy, [git.lenfortech.com](https://git.lenfortech.com/armandofredric) whereas the remaining patients had either maturation arrest or hypospermatogenesis. Although our results are higher than that reported in the literature, it should be noted that our population comprises patients with a good prognosis for sperm retrieval. Collectively, we were able to harvest sperm from 50% of patients, considering both TESA and ejaculated specimens. NOA patients with hypergonadotropic hypogonadism have an increased number of interstitial testicular lesions (containing no Leydig cells) and fibrosis compared with obstructive azoospermia patients (32).
<br>